PMID: 38817Jan 1, 1978

Blood level courses after i.v., i.m. and p.o. administration of theophylline ethylendiamine and pH-neutral solution of theophylline (author's transl)

Arzneimittel-Forschung
I ZimmermannW T Ulmer

Abstract

Serum theophylline concentration was measured in nine patients with chronic-obstructive lung disease following oral, i.m. and i.v. application. Two different preparations were tested: A pH-neutral solution of theophylline (Solosin) and theophylline-ethylenediamine. 208 mg of the pH-neutral solution of theophylline showed very similar serum concentrations as did 240 mg i.v. or p.o., but definitely higher than in the case of 360 mg i.m. theophylline ethylenediamine. After 10 min following the oral or the intramuscular application, serum concentrations were high enough for strong bronchodilating action. The oral dosages only reached the lower limit of optimal concentration for the best bronchodilation. There is a decrease of the blood concentrations by 50% after about 5 h. The bronchodilating effect subsided 2-4 h after i.v. injection.

Related Concepts

Intravenous Injections
Broncholytic Effect
Lung Diseases, Obstructive
Theophylline
Theophylline Assay
Bronchodilation
Monospan
Aminophylline
Bronchodilation [PE]
Chronic Obstructive Airway Disease

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.